Improving Pain Management of Sickle Cell Patients in the Emergency Department

Improving Pain Management of Sickle Cell Patients in the Emergency Department

Tuesday, May 19, 2026 12:32 PM to 12:40 PM · 8 min. (America/New_York)
M302 - M303: Level M
Abstracts
Operations/Quality Improvement/Administration

Information

Background and Objectives
Patients with Sickle Cell Disease (SCD) presenting to the Emergency Department (ED) for vaso-occlusive episodes (VOE) often face delays in pain management. National guidelines recommend priority triaging (ESI level 2) and a time-to-first-analgesic-dose (TFA) of less than 60 minutes. Our objective was to evaluate a multidisciplinary quality improvement (QI) initiative to increase the percentage of SCD patients achieving TFA under 60 minutes from a baseline of 29% to a target of 60%.
Methods
A multidisciplinary team utilized QI methodology involving Plan-Do-Study-Act (PDSA) cycles evaluating patients with a diagnosis of SCD and a chief complaint of pain from January 1, 2024, to November 30, 2025. Cycle1 (September 2024) established a departmental triage policy to assign ESI level 2 for all SCD-related pain. Cycle 2 (August 2025) launched a “heme alert”; an overhead notification, prioritizing high acuity side rooming and rapid evaluation by team members to improve overall care coordination. Statistical significance was determined with the utilization of standard t-tests and run charts were used to evaluate median times to medication administration.
Results
A total of 824 encounters were analyzed with 297 (36%) pre-intervention and 527 (64%) post-intervention. 413 (50.1%) male and a mean age of 31 (Std Dev 8). Regarding race, 767 (93%) identified as African American, 49 (6%) did not disclose or identify with a specific race and 8 (1%) identified as American Indian/Native American or White. Baseline performance, 143 (49%) were triaged as acuity level 2 compared to 296 (80%) after the first PDSA cycle and 149 (95%) in the second PDSA cycle. Median time to administration of first dose analgesia during the pre-intervention cycle was 81 minutes [IQR 56-116] compared to 68 minutes [46-106] after the first PDSA cycle, and 46 minutes [31-66] in the second PDSA cycle. Pre-intervention average TFA was 97 minutes with a decrease to 80 minutes after the first PDSA cycle (p< 0.001) and 55 minutes after the second PDSA cycle (p< 0.001).
Conclusion
Implementation of a standardized high-acuity triage policy and a rapid-response alert improved the timeliness of analgesia for patients with SCD. This system-wide, scalable model effectively bridges the gap between clinical guidelines and ED operational reality to improve health equity.
CME
0.75

Disclosures

Access the following link to view disclosures of session presenters, presenting authors, organizers, moderators, and planners:

Log in

See all the content and easy-to-use features by logging in or registering!